By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...
Roche has launched its Axelios gene sequencing machine, aiming to challenge Illumina's dominance in the genetic-testing ...
Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is selling a controlling interest in the company to a longtime supplier in ...
As news hit last week that Eli Lilly and Boehringer Ingelheim are cutting investments in Germany, Roche said it will not be following suit—for now. The Swiss major announced several years ago a 600 ...
FRANKFURT, June 9 (Reuters) - The Swiss pharmaceutical and diagnostics giant Roche (ROPC.S), opens new tab said it is sticking to its planned investments in Germany, unlike some of its competitors ...
Roche Holding struck a deal with Nurix Therapeutics NRIX0.25%increase; up pointing triangle to license an experimental blood-cancer drug for up to $2.3 billion, expanding its pipeline in oncology and ...
ZURICH, June 8 (Reuters) - Swiss pharmaceutical giant Roche (ROPC.S), opens new tab has entered an exclusive licensing and collaboration agreement with Nurix Therapeutics (NRIX.O), opens new tab ...
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK degrader that is set to go head-to-head against Eli Lilly’s Jaypirca in a phase 3 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results